BECTON DICKINSON & CO (BDX) Options Risk Score

Run a full BDX options risk analysis

See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.

Is it risky to sell options on BECTON DICKINSON & CO (BDX) right now?

BECTON DICKINSON & CO (BDX) currently scores 86 out of 100 for options catalyst risk (HIGH) over a 4-week expiry window. What pushes it there: an upcoming earnings report, 8 recent news items and 15 clinical-trial catalysts, all landing inside the 4-week window. On TickerRisk's scale 70 and above is HIGH, so a known event is scheduled inside this window — selling premium on BDX here is a bet on that event rather than on time decay. The score measures scheduled event exposure, not which way the stock will move.

BDX shows an IV Rank of 60, putting implied volatility in the middle of its one-year range — options are moderately priced, with a current implied volatility of about 34%. IV Rank is the most useful figure for deciding whether to sell or buy premium on BDX.

BDX reports on 2026-11-05. Any expiry beyond that date carries the gap, and the implied volatility priced in beforehand typically collapses the morning after.

BECTON DICKINSON & CO (BDX) current implied volatility and IV Rank

BECTON DICKINSON & CO (BDX) currently has an IV Rank of 60 with implied volatility around 34%, alongside a TickerRisk options-risk score of 86/100. That is roughly mid-range for this stock, meaning implied volatility offers neither a clear selling edge nor a bargain. Directional conviction matters more than vol here.

For what this number does and does not tell you about BDX's options, see IV Rank explained.

BECTON DICKINSON & CO (BDX) next earnings date — 2026-11-05

BECTON DICKINSON & CO (BDX) reports earnings on 2026-11-05 — about 15 days away, which falls inside a typical options expiry window. BDX's IV Rank is currently 60. Earnings are the single biggest scheduled catalyst for an overnight gap: implied volatility usually runs up into the report and collapses immediately after (the IV crush). Selling premium into the event captures that crush but exposes you to the gap; buying premium needs a move large enough to beat the elevated IV you paid.

TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer